Carsten Grullich
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma-Real-world data from the German research platform CARAT.
Journal: International journal of cancer
Published: December 03, 2024
Identification of genomic drivers for the therapeutic response of Cabozantinib in patients with metastatic renal cell carcinoma.
Journal: World journal of urology
Published: August 06, 2023
Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy.
Journal: Frontiers in immunology
Published: July 18, 2023
Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass).
Journal: European urology
Published: March 31, 2023
Couples coping with advanced prostate cancer: An explorative study on treatment decision making, mental deterioration, partnership, and psychological burden.
Journal: Urologic oncology
Published: April 16, 2021
Immunotherapy and tyrosine kinase inhibitors in first-line treatment of metastatic renal cell carcinoma-Which strategy when?
Journal: Der Urologe. Ausg. A
Published: October 07, 2020
Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N).
Journal: Journal of cancer research and clinical oncology
Published: June 28, 2020
First-line treatment of metastatic urothelial carcinoma : Update immuno-oncology
Journal: Der Urologe. Ausg. A
Published: June 06, 2020
Re: Maria J. Ribal, Philip Cornford, Alberto Briganti, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.056: Metastatic Prostate Cancer and COVID-19: Do Current Data Allow Modification of Established Treatment Recommendations?
Journal: European urology focus
Published: May 26, 2020
Patient expectations are better for immunotherapy than traditional chemotherapy for cancer.
Journal: Journal of cancer research and clinical oncology
Published: May 04, 2020
Last Updated: 09/26/2026